251. Cholecystokinin Inhibits Food Intake Independent of Interleukin-1.BETA. Expression in the Brain
- Author
-
Toru Hosoi, Yasuyuki Nomura, Libin Zhan, and Yasunobu Okuma
- Subjects
medicine.medical_specialty ,Central nervous system ,Pharmaceutical Science ,Hippocampus ,Neuropeptide ,Anorexia ,Biology ,digestive system ,Sincalide ,Eating ,Mice ,Internal medicine ,medicine ,Animals ,Cholecystokinin ,Pharmacology ,Dose-Response Relationship, Drug ,digestive, oral, and skin physiology ,Brain ,Interleukin ,General Medicine ,Vagus nerve ,Mice, Inbred C57BL ,Endocrinology ,medicine.anatomical_structure ,Hypothalamus ,medicine.symptom ,hormones, hormone substitutes, and hormone antagonists ,Interleukin-1 - Abstract
Increasing evidence has suggested that cholecystokinin (CCK) is involved in immune-to-brain communication. The afferent vagus nerve is an important component for transmitting peripheral immune signals to the brain, such as those determining interleukin (IL)-1beta expression in the brain and anorexia. In the present study, we investigated whether the anorexic effect of CCK, which also activates the afferent vagus nerve, is mediated via IL-1beta expression in the brain. CCK-8 dose-dependently (8-320 microg/kg, i.p.) inhibited food intake in mice. However, IL-1beta transcripts in the hypothalamus, the hippocampus and the brainstem were not significantly increased after the administration of CCK-8, even at the larger dose of 320 microg/kg. These findings suggest that the CCK-induced inhibition of food intake may be independent of IL-1beta production in the brain, and indicate the diverse role of CCK in the regulation of the neuro-immune interaction.
- Published
- 2003
- Full Text
- View/download PDF